The head and neck cancer immune landscape and its immunotherapeutic implications

Recent clinical trials have demonstrated a clear survival advantage in advanced head and neck squamous cell carcinoma (HNSCC) patients treated with immune checkpoint blockade. These emerging results reveal that HNSCC is one of the most promising frontiers for immunotherapy research. However, further...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JCI Insight
Autors principals: Mandal, Rajarsi, Şenbabaoğlu, Yasin, Desrichard, Alexis, Havel, Jonathan J., Dalin, Martin G., Riaz, Nadeem, Lee, Ken-Wing, Ganly, Ian, Hakimi, A. Ari, Chan, Timothy A., Morris, Luc G.T.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Clinical Investigation 2016
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5070962/
https://ncbi.nlm.nih.gov/pubmed/27777979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.89829
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars